Article Details

Li Ka-Shing's Horizon Ventures co-leads $40m round in infant probiotic firm Evolve

Retrieved on: 2018-06-13 08:11:15

Tags for this article:

Click the tags to see associated articles and topics

Li Ka-Shing's Horizon Ventures co-leads $40m round in infant probiotic firm Evolve. View article details on hiswai:

Excerpt

<div>Patrick Zhang, lead investor at <b>Horizons Ventures</b> and Evolve BioSystems Board member, said Evolve has the potential to make “tremendous societal ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up